Indian J Sex Transm Dis Indian J Sex Transm Dis
Official Publication of the Indian Association for the Study of Sexually Transmitted Diseases
Indian J Sex Transm Dis
The Journal | Search | Ahead Of Print | Current Issue | Archives | Instructions | Subscribe | Login    Users online: 1335   Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size


 
  Table of Contents  
LETTER TO EDITOR
Year : 2017  |  Volume : 38  |  Issue : 1  |  Page : 100-101
 

Exploring the scope of enhanced gonococcal antimicrobial surveillance programme


Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Kancheepuram, Tamil Nadu, India

Date of Web Publication30-Mar-2017

Correspondence Address:
Dr. Saurabh RamBihariLal Shrivastava
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, 3rd Floor, Ammapettai Village, Thiruporur, Guduvancherry Main Road, Sembakkam Post, Kancheepuram - 603 108, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7184.203434

Rights and Permissions

 



How to cite this article:
Shrivastava SR, Shrivastava PS, Ramasamy J. Exploring the scope of enhanced gonococcal antimicrobial surveillance programme. Indian J Sex Transm Dis 2017;38:100-1

How to cite this URL:
Shrivastava SR, Shrivastava PS, Ramasamy J. Exploring the scope of enhanced gonococcal antimicrobial surveillance programme. Indian J Sex Transm Dis [serial online] 2017 [cited 2019 Nov 19];38:100-1. Available from: http://www.ijstd.org/text.asp?2017/38/1/100/203434


Sir,

Worldwide, sexually transmitted infections (STIs) tend to cast a major influence on the sexual and reproductive health status and are one of the most common ailments for which health care services are utilized.[1] In fact, more than 1 million people every day acquire STI while on an annual basis, almost 500 million people acquire any of the four major STIs.[1] Although antibiotic resistance has emerged against most of the STIs, it has been anticipated that very soon management of gonorrhea infection will be intractable.[2] Further, reports of resistance of gonorrhea to antibiotics have been observed in 36 nations, including cases of multidrug-resistant gonorrhea (viz., resistance to penicillin, broad spectrum antibiotics, cephalosporins, etc.).[1],[2]

The reports of multidrug resistance against gonorrhea is a major public health concern, as a disease which could be cured by taking a single dose of antibiotic, might now result in long-term complications such as infertility, pregnancy complications, and neonatal blindness.[3] This is a serious issue for the policy makers to contend with, as most of the developing nations are already struggling with resource/logistic constraints, poor awareness, stigma, limited contact tracing or case-holding, and shortcomings in screening activities.[1],[2],[3]

The primary strategy for reducing the spread of gonorrhea is to ensure early detection and treatment and to extend supportive care to the people.[3] Both of these strategies are quite indispensable as most of the people hesitate to avail health care services, and hence, it becomes imperative to provide effective treatment whenever people come to health centers.[3],[4] To contain the problem, the World Health Organization has implemented the Gonococcal Antimicrobial Surveillance Programme (GASP) to ascertain the trends of spread and emergence of gonorrhea resistance.[3]

Further, an enhanced version of the GASP has been initiated in Thailand to obtain an accurate estimate about the number of people with gonococcal infections, their demographic parameters, and type of treatment needed, to eventually enable provision of nondiscriminatory health care.[3] This initiative aims to improve on the existing surveillance system in the country by providing standardized guidelines for testing laboratory specimens, emphasizing on eliciting surplus clinical/demographic/behavioral information, and in altering the treatment strategy depending on the pattern of gonococcal antibiotic resistance.[3] Further, these estimates can be utilized in the assessment of the global trends and to ensure comparison between various nations.[3],[4],[5] Moreover, it has been advocated that any nation which can ascertain and then only provide appropriate therapeutic care can significantly address the problem of gonorrhea.[4],[5] In addition, a simultaneous improvement in the existing STI package of services, better emphasis on behavior alterations and compliance with the treatment guidelines, and ensuring involvement of the community in different stages of the program can play a significant role in enhancing the utility of the services.[1],[3]

In conclusion, the strategy of enhanced gonococcal resistance surveillance program can play a crucial role in significantly improving the treatment outcome of gonoccal infections in the coming years.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
World Health Organization. Sexually Transmitted Infections (STIs) – Fact Sheet No. 110; 2013. Available from: http://www.who.int/mediacentre/factsheets/fs110/en/. [Last accessed on 2015 Nov 05].  Back to cited text no. 1
    
2.
World Health Organization. Antibiotic Resistance – Fact Sheet; 2015. Available from: http://www.who.int/mediacentre/factsheets/antibiotic-resistance/en/. [Last accessed on 2015 Nov 08].  Back to cited text no. 2
    
3.
Spiteri G, Cole M, Unemo M, Hoffmann S, Ison C, van de Laar M. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) – A sentinel approach in the European Union (EU)/European Economic Area (EEA). Sex Transm Infect 2013;89 Suppl 4:iv16-8.  Back to cited text no. 3
    
4.
World Health Organization. Clinics in Thailand Target Antibiotic-resistant Gonorrhea; 2015. Available from: http://ww.who.int/features/2015/thailand-gonorrhea/en/. [Last accessed on 2015 Nov 19].  Back to cited text no. 4
    
5.
Hançali A, Ndowa F, Bellaji B, Bennani A, Kettani A, Charof R, et al. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the global fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme. Sex Transm Infect 2013;89 Suppl 4:iv24-7.  Back to cited text no. 5
    




 

Top
Print this article  Email this article
 

    

 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (283 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed895    
    Printed18    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal